Pocket guide to evaluations of drug interactions

A condensed version of First DataBank's ""Evaluations of Drug Interactions"", a 1600-page, peer-reviewed publication that is updated six times a year. This pocket guide is designed to facilitate quick access to the information most frequently needed by busy health practition...

Full description

Saved in:
Bibliographic Details
Other Authors: Zucchero, Frederick J. (Editor), Hogan, Mark J. (Editor), Sommer, Christine D. (Editor)
Format: Book
Language:English
Published: Washington, D.C American Pharmaceutical Association 2002
Edition:Fourth Edition
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a2200000#i 4501
001 wils-331329
005 2022101682828
008 221116t2002 -US a# #001 deng D
020 # # |a 9781582120300  |q paperback 
020 # # |a 1582120307  |q paperback 
040 # # |a UiTM  |e rda 
041 0 # |a English 
060 0 0 |a QV 39 
090 0 0 |a QV39  |b P739 2002 
245 0 0 |a Pocket guide to evaluations of drug interactions  |c editors, Frederic J. Zucchero, Mark J. Hogan and Christine D. Sommer 
250 # # |a Fourth Edition 
264 # 1 |a Washington, D.C  |b American Pharmaceutical Association  |c 2002 
264 # 4 |c ©2002 
300 # # |a viii, 491 pages  |b illustrations  |c 22 cm 
336 # # |a text  |b txt  |2 rdacontent 
337 # # |a unmediated  |b n  |2 rdamedia 
338 # # |a volume  |b nc  |2 rdacarrier 
520 # # |a A condensed version of First DataBank's ""Evaluations of Drug Interactions"", a 1600-page, peer-reviewed publication that is updated six times a year. This pocket guide is designed to facilitate quick access to the information most frequently needed by busy health practitioners. The guide contains just over 1000 drug interaction monographs organized by drug class, including interactions between drugs and nutritional supplements. Ninety-four of the monographs are new or revised for this fourth edition. Most monographs feature eight pieces of information: the title by generic name of the interacting drugs; a significance code based on the interaction's potential harm to the patient and its frequency and predictability; a statement on the interaction's potential effects; patient management recommendations; a summary of findings of studies in the literature; a discussion of pharmacologically-, pharmacokinetically-, or chemically-related drugs; a comment on the postulated mechanism for the drug interaction; and a cross reference to the more detailed information found in the ""Evaluations of Drug Interactions"" monograph.The appendix includes complete lists of the agents in a specified drug class, and a list of monographs with Code I (highly clinically significant) interactions. The index provides a comprehensive cross reference to the most clinically significant drug interactions, organized by generic name 
650 1 2 |a Drug interactions 
650 2 2 |a Drug interactions Handbooks, manuals, etc 
650 2 2 |a Handbooks and manuals 
700 1 # |a Zucchero, Frederick J.  |e editor 
700 1 # |a Hogan, Mark J.  |e editor 
700 1 # |a Sommer, Christine D.  |e editor 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=331329 
964 # # |c BOK  |d 01 
998 # # |a 00250##a006.2.2||00250##b006.2.2||00264#1a006.2.2||00264#1b006.2.2||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00520##a006.2.2||00520##b006.2.2||